Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioSyntagma

BioSyntagma
2015 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$735K LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a precision medicine company intended to develop a microfluidic platform. The company's services include developing a microfluidic platform which allows researchers to identify single cells of interest in Formalin Fixed Paraffin Embedded (FFPE) or fresh frozen tissue, ablate the cell and transfer its contents to a downstream collection device, enabling healthcare givers to achieve a complete and informed understanding of the patient's cancer and match them with relevant therapies and recommended course of actions that prevent acquired drug resistance.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Social/Platform Software
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 1475 North Scottsdale Road
  • Suite 200
  • Scottsdale, AZ 85257
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioSyntagma’s full profile, request a free trial.

BioSyntagma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jan-2018 $735K Completed Startup
3. Accelerator/Incubator 20-Sep-2017 Completed Startup
2. Grant 01-Jan-2017 $214K Completed Startup
1. Grant 17-Mar-2016 $30K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BioSyntagma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Center for Entrepreneurial Innovation Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Flinn Foundation Accelerator/Incubator 000 0000 000000 0

BioSyntagma Executive Team (3)

Name Title Board
Seat
Contact
Info
David Richardson Founding Member & Chief Executive Officer
Dmitry Derkach MD Chief Scientific Officer
Colleen Ziegler Co-Founder & Research Technician

BioSyntagma Board Members (1)

Name Representing Role Since Contact
Info
Steve Pemberton BioSyntagma Board Member 000 0000